E. Ohman J:or Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

E. Ohman J:or Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,300	Closed	-$733K	–	430
2021 Q4	$733K	Hold	8,300	–	–	0.02%	364
2021 Q3	$642K	Sell	8,300 -1,300	-14%	-$100K	0.02%	366
2021 Q2	$801K	Hold	9,600	–	–	0.03%	330
2021 Q1	$725K	Hold	9,600	–	–	0.03%	315
2020 Q4	$842K	Buy	9,600 +2,500	+35%	+$219K	0.03%	251
2020 Q3	$540K	Sell	7,100 -258,137	-97%	-$19.6M	0.03%	273
2020 Q2	$32.7M	Buy	265,237 +27,317	+11%	+$3.37M	1.88%	15
2020 Q1	$20.1M	Buy	237,920 +27,497	+13%	+$2.32M	1.47%	20
2019 Q4	$17.8M	Buy	210,423 +39,830	+23%	+$3.37M	0.98%	27
2019 Q3	$11.5M	Buy	170,593 +166,393	+3,962%	+$11.2M	0.72%	33
2019 Q2	$360K	Sell	4,200 -4,100	-49%	-$351K	0.02%	285
2019 Q1	$737K	Hold	8,300	–	–	0.05%	193
2018 Q4	$707K	Hold	8,300	–	–	0.05%	181
2018 Q3	$805K	Buy	8,300 +800	+11%	+$77.6K	0.05%	192
2018 Q2	$707K	Buy	7,500 +2,700	+56%	+$254K	0.05%	195
2018 Q1	$389K	Sell	4,800 -1,200	-20%	-$97.3K	0.03%	301
2017 Q4	$535K	Buy	6,000 +900	+18%	+$80.3K	0.04%	252
2017 Q3	$475K	Buy	5,100 +100	+2%	+$9.31K	0.04%	268
2017 Q2	$454K	Hold	5,000	–	–	0.05%	267
2017 Q1	$439K	Buy	5,000 +1,700	+52%	+$149K	0.05%	269
2016 Q4	$273K	Hold	3,300	–	–	0.04%	329
2016 Q3	$305K	Hold	3,300	–	–	0.05%	281
2016 Q2	$257K	Hold	3,300	–	–	0.04%	297
2016 Q1	$272K	Hold	3,300	–	–	0.05%	267
2015 Q4	$346K	Hold	3,300	–	–	0.06%	232
2015 Q3	$348K	Hold	3,300	–	–	0.09%	212
2015 Q2	$451K	Hold	3,300	–	–	0.11%	189
2015 Q1	$411K	Hold	3,300	–	–	0.1%	212
2014 Q4	$298K	Hold	3,300	–	–	0.07%	262
2014 Q3	$238K	Hold	3,300	–	–	0.06%	316
2014 Q2	$205K	Hold	3,300	–	–	0.05%	363
2014 Q1	$225K	Hold	3,300	–	–	0.06%	332
2013 Q4	$229K	Hold	3,300	–	–	0.05%	328
2013 Q3	$238K	Hold	3,300	–	–	0.06%	320
2013 Q2	$184K	Buy	+3,300	New	+$184K	0.05%	365